Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Team Grant: Childhood Cancer - Late Effects of Treatment -LOI

McMaster University

$5,000.00

An evaluation of DNA fragmentation in semen specimens pre and post-cancer treatment

FY 2010-11

Summary
Quality of life issues are of paramount importance in this cohort of patients, especially the ability to have their own biological children. While the first priority is to save the life of the patient we also need to think about their quality of life as cancer survivors. However, little is know about the effects of potentially gonadotoxic cancer therapy on sperm quality and function. Our team will explore why some patients become infertile after chemotherapy treatments, while others are unaffected. In addition we will study the effect of cancer treatments on DNA fragmentation and look for biomarkers of infertility. The team will use a HaloSperm© assay to establish a DNA fragmentation index (DFI) as a measure of fertility potential in patients pre-chemotherapy and post chemo, at 3, 6, and 9 months intervals. Our team challenges the assumption that if spermatogenesis appears intact after cancer treatment then the patient is still fertile.
Program
Team Grant: Childhood Cancer - Late Effects of Treatment -LOI
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
222166
Name
Portwine Carol A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Special Cases
Projecttitle
An evaluation of DNA fragmentation in semen specimens pre and post-cancer treatment
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Team Grant: Childhood Cancer - Late Effects of Treatment -LOI
Keyworddelim
Dna Fragmentation; Fertility Biomarkers; Oncofertility; Quality Of Life; Reproduction
Abstract
Quality of life issues are of paramount importance in this cohort of patients, especially the ability to have their own biological children. While the first priority is to save the life of the patient we also need to think about their quality of life as cancer survivors. However, little is know about the effects of potentially gonadotoxic cancer therapy on sperm quality and function. Our team will explore why some patients become infertile after chemotherapy treatments, while others are unaffected. In addition we will study the effect of cancer treatments on DNA fragmentation and look for biomarkers of infertility. The team will use a HaloSperm© assay to establish a DNA fragmentation index (DFI) as a measure of fertility potential in patients pre-chemotherapy and post chemo, at 3, 6, and 9 months intervals. Our team challenges the assumption that if spermatogenesis appears intact after cancer treatment then the patient is still fertile.
Competitiondate
201012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Portwine, Carol A; Barr, Ronald D; Chan, Anthony Kam C
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $5,000~ $0~